Literature DB >> 23210849

Cantharidin as an antitumor agent: a retrospective review.

L P Deng1, J Dong, H Cai, W Wang.   

Abstract

This review summarizes the progress that has been made recently in the medicinal chemistry of cantharidin, a potent antitumor agent from traditional Chinese medicine. Thousands of analogs have been synthesized on the basis of cantharidin, a part of which shows excellent properties, in particular, norcantharidin and norcantharimide. Despite the enormous efforts made, the intriguing bioactivities, mechanism, indications, and their interplay are still ill-defined. This review provides our up-to-date understanding in connection with the therapeutic use, mechanism, structure-activity relationship (SAR) and interesting properties of cantharidin analogs. Considerable development in the design of cantharidin analogs, in combination with mechanistic studies, has laid a foundation for transforming novel antitumor drugs into the clinic.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23210849     DOI: 10.2174/092986713804806711

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  17 in total

1.  The natural compound cantharidin induces cancer cell death through inhibition of heat shock protein 70 (HSP70) and Bcl-2-associated athanogene domain 3 (BAG3) expression by blocking heat shock factor 1 (HSF1) binding to promoters.

Authors:  Joo Ae Kim; Youngmi Kim; Byoung-Mog Kwon; Dong Cho Han
Journal:  J Biol Chem       Date:  2013-08-27       Impact factor: 5.157

Review 2.  Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives.

Authors:  Yulin Ren; A Douglas Kinghorn
Journal:  Bioorg Med Chem       Date:  2021-01-09       Impact factor: 3.641

3.  Role of S100A3 in human colorectal cancer and the anticancer effect of cantharidinate.

Authors:  Bin Liu; Wen-Yi Sun; Chen-Yang Zhi; Tian-Cheng Lu; Hai-Mei Gao; Jian-Hua Zhou; Wei-Qun Yan; Hai-Cheng Gao
Journal:  Exp Ther Med       Date:  2013-10-14       Impact factor: 2.447

4.  FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells.

Authors:  Qiao-Yan Zhang; Xiao-Qiang Yue; Yi-Ping Jiang; Ting Han; Hai-Liang Xin
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

5.  Role of S100A3 in human hepatocellular carcinoma and the anticancer effect of sodium cantharidinate.

Authors:  Ran Tao; Zhong-Feng Wang; Wei Qiu; Yu-Fang He; Wei-Qun Yan; Wen-Yi Sun; Hai-Jun Li
Journal:  Exp Ther Med       Date:  2017-04-04       Impact factor: 2.447

6.  Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin αIIb β3 binding in human platelets.

Authors:  Chih-Hsuan Hsia; Wan-Jung Lu; Kuan-Hung Lin; Duen-Suey Chou; Pitchairaj Geraldine; Thanasekaran Jayakuma; Nen-Chung Chang; Joen-Rong Sheu
Journal:  J Cell Mol Med       Date:  2018-01-25       Impact factor: 5.310

Review 7.  Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways.

Authors:  Faiza Naz; Yixin Wu; Nan Zhang; Zhao Yang; Changyuan Yu
Journal:  Molecules       Date:  2020-07-19       Impact factor: 4.411

Review 8.  Recent Advances in Herbal Medicines for Digestive System Malignancies.

Authors:  Jiyao Sheng; Xiaohan Zou; Ziqian Cheng; Yien Xiang; Wei Yang; Yang Lin; Ranji Cui
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

9.  Induction of Suicidal Erythrocyte Death by Cantharidin.

Authors:  Kousi Alzoubi; Jasmin Egler; Marilena Briglia; Antonella Fazio; Caterina Faggio; Florian Lang
Journal:  Toxins (Basel)       Date:  2015-07-28       Impact factor: 4.546

10.  Comparison of cantharidin toxicity in breast cancer cells to two common chemotherapeutics.

Authors:  Katie M Kern; Jennifer R Schroeder
Journal:  Int J Breast Cancer       Date:  2014-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.